acid reflux on semaglutide from Semaglutide: Causes & Management Can Semaglutide Give You Heartburn?

The FDA approved oral semaglutide (Rybelsus) in 2019, and other oral GLP-1 medications like orforglipron are in development

What does the evidence say about frequency versus background rates

Because large studies did not show robust, reproducible weightloss outcomes, development as a formal obesity drug was discontinued, and AOD9604 today is typically used offlabel as a wellness or bodycomposition adjunct rather than an FDAapproved obesity medication

Starting January 1, 2026, these medications will no longer be covered for weight loss or weight loss-related indications: Ozempic Rybelsus Mounjaro Victoza Byeta Bydureon Trulicity Ensuring Continuation of Therapy If you are currently prescribed any GLP-1 medication for an approved indication, it is important to ensure your prescriber includes the appropriate diagnosis code (ICD-10) when submitting your prescription